Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium.

Literature DB >> 10506626

Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium.

R F Kefford¹, J A Newton Bishop, W Bergman, M A Tucker.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1999 PMID： 10506626 DOI： 10.1200/JCO.1999.17.10.3245

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

46 in total

1. Localization of a novel melanoma susceptibility locus to 1p22.

Authors: Elizabeth Gillanders; Suh-Hang Hank Juo; Elizabeth A Holland; MaryPat Jones; Derek Nancarrow; Diana Freas-Lutz; Raman Sood; Naeun Park; Mezbah Faruque; Carol Markey; Richard F Kefford; Jane Palmer; Wilma Bergman; D Timothy Bishop; Margaret A Tucker; Brigitte Bressac-de Paillerets; Johan Hansson; Mitchell Stark; Nelleke Gruis; Julia Newton Bishop; Alisa M Goldstein; Joan E Bailey-Wilson; Graham J Mann; Nicholas Hayward; Jeffrey Trent
Journal: Am J Hum Genet Date: 2003-07-03 Impact factor: 11.025

Review 2. Clinical applications of melanoma genetics.

Authors: Michele Gabree; Devanshi Patel; Linda Rodgers
Journal: Curr Treat Options Oncol Date: 2014-06

3. Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone.

Authors: Jennifer M Taber; Lisa G Aspinwall; Tammy K Stump; Wendy Kohlmann; Marjan Champine; Sancy A Leachman
Journal: J Behav Med Date: 2015-07-16

Review 4. Barriers to risk-understanding and risk-reduction behaviors among individuals with a family history of melanoma.

Authors: Laura Fitzpatrick; Jennifer L Hay
Journal: Melanoma Manag Date: 2014-12-04

Review 5. Genetic determinants of cutaneous melanoma predisposition.

Authors: Durga Udayakumar; Bisundev Mahato; Michele Gabree; Hensin Tsao
Journal: Semin Cutan Med Surg Date: 2010-09

6. Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.

Authors: Nicholas J Taylor; Nandita Mitra; Lu Qian; Marie-Françoise Avril; D Timothy Bishop; Brigitte Bressac-de Paillerets; William Bruno; Donato Calista; Francisco Cuellar; Anne E Cust; Florence Demenais; David E Elder; Anne-Marie Gerdes; Paola Ghiorzo; Alisa M Goldstein; Thais C Grazziotin; Nelleke A Gruis; Johan Hansson; Mark Harland; Nicholas K Hayward; Marko Hocevar; Veronica Höiom; Elizabeth A Holland; Christian Ingvar; Maria Teresa Landi; Gilles Landman; Alejandra Larre-Borges; Graham J Mann; Eduardo Nagore; Håkan Olsson; Jane M Palmer; Barbara Perić; Dace Pjanova; Antonia L Pritchard; Susana Puig; Helen Schmid; Nienke van der Stoep; Margaret A Tucker; Karin A W Wadt; Xiaohong R Yang; Julia A Newton-Bishop; Peter A Kanetsky
Journal: J Am Acad Dermatol Date: 2019-02-05 Impact factor: 11.527

Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium.

1. Localization of a novel melanoma susceptibility locus to 1p22.

Review 2. Clinical applications of melanoma genetics.

3. Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone.

Review 4. Barriers to risk-understanding and risk-reduction behaviors among individuals with a family history of melanoma.

Review 5. Genetic determinants of cutaneous melanoma predisposition.

6. Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.

Review 7. Collaborative cancer epidemiology in the 21st century: the model of cancer consortia.

8. Perceived intrafamily melanoma risk communication.

9. Melanoma high-risk families' perceived health care provider risk communication.

10. Cancer risk assessment for the primary care physician.